Hemocytopenias in Antiphospholipid Syndrome

  • C. Montecucco
  • R. Caporali

Abstract

Thrombocytopenia is included among the features of the human antiphospholipid syndrome (APS) [1] and is present in some animal models [2]. Hemolytic anemia can also be found in APS although less frequently than thrombocytopenia [1].

Keywords

Hepatitis Heparin Anemia Warfarin Vasculitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. I. Hughes GRV. The antiphospholipid syndrome. Ten years on. Lancet 1993; 324: 341–344.CrossRefGoogle Scholar
  2. 2.
    Aron AL, Cuellar RL, Brey RL, Maceown S, Espinoza LR, Shoenfeld Y. Early onset of autoimmunity in MRL/++ mice following immunization with beta 2 glycoprotein I. Clin Exp Immunol 1995; 101: 78–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Finazzi G. The Italian Registry of antiphospholipid antibodies. Haematologica 1997; 82: 101–5.PubMedGoogle Scholar
  4. 4.
    Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366–74.Google Scholar
  5. 5.
    Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A et al. Comparison of the primary and secondary antiphospholipid syndrome: a european multicenter study of 114 patients. Am J Med 1994; 96: 3–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990; 112: 682–698.PubMedGoogle Scholar
  7. 7.
    Jouhikainen T, Stephansson E, Leirisalo-Repo M Lupus anticoagulant as a prognostic marker in systemic lupus erythematosus. Br J Rheumatol 1993; 32: 568–573.PubMedCrossRefGoogle Scholar
  8. 8.
    Abu-Shakra M, Gladman DD, Urowitz MB, Farewell V. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations. Am J Med 1995; 99: 624–628.PubMedCrossRefGoogle Scholar
  9. 9.
    Nojima J, Suehisa E, Kuratsune H, Machii T, Toku M, Tada H. High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant. Am J Hematol 1998; 58: 55–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Ravelli A, Caporali R, Bianchi E, Viola S, Solmi M, Montecucco C, Martini A. Anticardiolipin syndrome in childhood: a report of two cases. Clin Exp Rheumatol 1990; 8: 95–98.PubMedGoogle Scholar
  11. 11.
    Falcini F, Taccetti G, Tragani S, Tafi L, Petralli S, Matucci-Cerinic M. Primary antiphospholipid syndrome: a report of two pediatric cases. J Rheumatol 1991; 18: 1085–1087.PubMedGoogle Scholar
  12. 12.
    Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994; 148: 398–402.PubMedCrossRefGoogle Scholar
  13. 13.
    Seaman DE, Londino AV Jr, Kwoh CK, Medsger TA Jr, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus Erythematosus. Pediatrics 1995; 96: 1040–1045.PubMedGoogle Scholar
  14. 14.
    Ravelli A, Caporali R, Montecucco C, Martini A. The antiphospholipid syndrome in childhood. J Rheumatol 1996; 23: 1121–1122.PubMedGoogle Scholar
  15. 15.
    La Rosa L, Covini G, Galperin C, Catelli L, Del Papa N, Reina GL et al. Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies. Clin Exp Immunol 1998; 112: 144–151.PubMedCrossRefGoogle Scholar
  16. 16.
    Laperche S, Abuaf N, Meyer O, Carsique R, Deschamps A, Rajoely B et al. Association of antimitochondrial antibodies type 5 and anti-beta 2 glycoprotein I antibodies in the antiphospholipid syndrome. J Rheumatol 1994; 21: 1678–1683.PubMedGoogle Scholar
  17. 17.
    Font J, Lopez-Soto A, Cervera R, Casals FJ, Reverter JC, Munoz FJ et al. Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients. Thromb Res 1997; 86: 37–48.PubMedCrossRefGoogle Scholar
  18. 18.
    Cuadrado MJ, Tinahones F, Camps MT, de Ramon E, Gomez-Zumaquero JM, Mujic F et al. Antiphospholipid, anti-beta 2-glycoprotein I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome. Quart J Med 1998; 91: 619–626.CrossRefGoogle Scholar
  19. 19.
    Cabiedes J, Cabral AR, Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899–1906.PubMedGoogle Scholar
  20. 20.
    Amengual O, Atsumi T, Khamashta MA, Koike T, Hughes GR. Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1996; 35: 1239–1243.PubMedCrossRefGoogle Scholar
  21. 21.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol 1998; 25: 667–674.PubMedGoogle Scholar
  22. 22.
    Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D’Cruz Det al. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. J Rheumatol 1998; 25: 2131–2134.PubMedGoogle Scholar
  23. 23.
    Ravelli A, Caporali R, Ballardini G, Scatola C, Montecucco C, Martini A. Relationship between anticardiolipin and anti-beta 2 glycoprotein I antibodies in pediatric systemic lupus erythematosus. Arthritis Rheum 1996; 39:S 190.Google Scholar
  24. 24.
    Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CC, Loizou S et al. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol 1985; 59: 227–230.PubMedCrossRefGoogle Scholar
  25. 25.
    Caporali R, Longhi M, De Gennaro F, Di Lauro M, Carnevale R, Montecucco C. Antiphospholipid antibody-associated thrombocytopenia in autoimmune dieases. Med Sci Res 1988; 16: 537–539.Google Scholar
  26. 26.
    Alarcon-Segovia D, Delezé M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353–365.PubMedGoogle Scholar
  27. 27.
    Sachse C, Luthke K, Hartung K, Liedvogel B, Kalden JR, Peter HH et al. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group. Rheumatol Int 1995; 15: 23–29.PubMedCrossRefGoogle Scholar
  28. 28.
    Lopez LR, Santos ME, Espinoza LR, La Rosa FG. Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia and recurrent abortion. Am J Clin Pathol 1992; 98: 449–454.PubMedGoogle Scholar
  29. 29.
    Tajima C, Suzuki Y, Mizushima Y, Ichikawa Y (1998) Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vas -culitis. J Rheumatol 1998; 25: 1730–176.Google Scholar
  30. 30.
    Caporali R, Ravelli A, De Gennaro F, Neirotti G, Montecucco C, Martini A. Prevalence of anticardiolipin antibodies in juvenile chronic arthritis. Ann Rheum Dis 1991; 50: 599–601.PubMedCrossRefGoogle Scholar
  31. 31.
    Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ et al. Antiphospholipid antibodies in primary Sjogren’s syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 1997; 15: 361–365.PubMedGoogle Scholar
  32. 32.
    D’Annunzio G, Caporali R, Montecucco C, Vitali L, Alibrandi A, Stroppa P et al. Anticardiolipin antibodies in first-degree relatives of type 1, insulin dependent diabetic patients. J Pediatr Endocrinol Metab 1998; 11: 21–25.PubMedGoogle Scholar
  33. 33.
    Caporali R, Ravelli A, Romenghi B, Montecucco C, Martini A. Antiphospholipid antibody-associated thrombosis in juvenile chronic arthritis. Arch Dis Child 1992; 67: 1384–1386.PubMedCrossRefGoogle Scholar
  34. 34.
    Peacock NW, Levine SP. Case report: The lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med Sci 1994; 307: 346–349.PubMedCrossRefGoogle Scholar
  35. 35.
    Orlando E, Cortellazzo S, Marchetti M, Sanfratello R, Barbui T. Prolonged bleeding time in patients with lupus anticoagulant. Thromb Haemost 1992; 68: 495–499.PubMedGoogle Scholar
  36. 36.
    Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol 1996; 93: 1–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985; 15: 254–262.PubMedGoogle Scholar
  38. 38.
    Harris EN, Gharavi AE, Hedge V, Derue G, Morgan SH, Englere H et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 1985; 59: 231–234.PubMedCrossRefGoogle Scholar
  39. 39.
    Hasselaar P, Derksen RHWM, Blokzijl L, de Groot P. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 1990; 63: 169–173PubMedGoogle Scholar
  40. 40.
    Out HJ, de Groot PG, van Vliet M, de Gast GC, Nieuwenhuis HK, Derksen RH. Antibodies to platelets in patients with anti-phospholipid antibodies. Blood 1991; 77: 2655–2659.PubMedGoogle Scholar
  41. 41.
    Revers EM, Smeets EF, Confurius P, Zwaal RFA. Physiology of membrane lipid asymmetry. Lupus 1994; 3: 235–240.CrossRefGoogle Scholar
  42. 42.
    Robbins DL, Leung S, Miller-Blair DJ, Ziboh V. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with antiphospholipid syndrome. J Rheumatol 1998; 25: 51–56.PubMedGoogle Scholar
  43. 43.
    Arvieux J, Roussel B, Pouzol P, Colomb MG. Platelet activating properties of murine monoclonal antibodies to beta 2 glycoprotein I? Thromb Haemost 1993; 70: 336–341.PubMedGoogle Scholar
  44. 44.
    Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies.Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 1994; 7: 335–348.PubMedCrossRefGoogle Scholar
  45. 45.
    Galli M, Daldossi M, Barbui T. Anti-glycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1994; 71: 571–75.PubMedGoogle Scholar
  46. 46.
    Godeau B, Piette JC, Fromont P, Intrator L, Schaeffer A, Bierling P. Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 1997; 98: 873–879.PubMedCrossRefGoogle Scholar
  47. 47.
    Panzer S, Gschwandtner ME, Hutter D, Spitzauer S, Pabinger I. Specificities of platelet autoantibodies in patients with lupus anticoagulants in primary antiphospholipid syndrome. Ann Hematol 1997; 74: 239–242.PubMedCrossRefGoogle Scholar
  48. 48.
    Fabris F, Steffan A, Cordiano I, Borzini P, Luzzatto G, Randi ML et al. Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia. Eur J Haematol 1994; 53: 232–236.PubMedCrossRefGoogle Scholar
  49. 49.
    Macchi L, Rispal P, Clofent-Sanchez G, Pellegrin JL, Nurden P, Leng B et al. Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia. Br J Haematol 1997; 98: 336–341.PubMedCrossRefGoogle Scholar
  50. 50.
    Lipp E, von Felten A, Sax H, Muller D, Berchtold P. Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia. Eur J Haematol 1998; 60: 283–288.PubMedCrossRefGoogle Scholar
  51. 51.
    Shi W, Chong BH, Chesterman CN. Beta 2 glycoprotein I is a requirement for anticardiolipin binding to activated platelets: differences with lupus anticoagulants. Blood 1993; 81: 1255–1262.PubMedGoogle Scholar
  52. 52.
    Stasi S, Stipa E, Masi M, Oliva F, Sciarra A, Perotti A et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994; 84: 4203–4208.PubMedGoogle Scholar
  53. 53.
    Deleze M, Oria CV, Alarcon-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans’ syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1988; 15: 611–615.PubMedGoogle Scholar
  54. 54.
    Stasi R, Stipa E, Masi M, Cecconi M, Scimò MT, Oliva F et al. Long term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995; 98: 437–442.CrossRefGoogle Scholar
  55. 55.
    Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 1996; 75: 536–541.PubMedGoogle Scholar
  56. 56.
    Jackson J, McDonald M, Casey E, Kelleher S, Murray A, Temperley I et al. Mixed connective tissue disease with arterial thrombosis, antiphospholipid antibodies and heparin induced thrombocytopenia. J Rheumatol 1990; 17: 1523–1524.PubMedGoogle Scholar
  57. 57.
    Lasne D, Saffroy R, Bachelot C, Vincenot A, Rendu F, Papo T. Test for heparin-induced thrombocytopenia in primary antiphospholipid syndrome. Br J Rheumatol 1997; 97: 939.Google Scholar
  58. 58.
    Fiorin F, Steffan A, Pradella P, Bizzaro N, Potenza R, De Angelis V. IgG platelet antibodies in EDTA-dependent pseudothrombocytopenia bind to platelet membrane glycoprotein Iib. Am J Clin Pathol 1998; 110: 178–183.PubMedGoogle Scholar
  59. 59.
    Bizzaro N, Brandalise M. EDTA-dependent pseudothrombocytopenia. Association with antiplatelet and antiphospholipid antibodies. Am J Clin Pathol 1995; 103: 103–107.PubMedGoogle Scholar
  60. 60.
    Hazeltine M, Rauch J, Danoff D, Esdaile JM, Tannenbaum H. Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs’ and hypocomplementemia. J Rheumatol 1988; 15: 80–86.PubMedGoogle Scholar
  61. 61.
    Tincani A, Meroni PL, Brucato A, Zanussi C, Allegri F, Mantelli P et al. Anti-phospholipid and antimitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 1985; 3: 321–326.PubMedGoogle Scholar
  62. 62.
    Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodes: isotype, distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Montecucco C, Longhi M, Caporali R, De Gennaro F. Hematological abnormalities associated with anticardiolipin antibodies. Haematologica 1989; 74: 195–204.PubMedGoogle Scholar
  64. 64.
    Mueh JR, Herbst KD, Rappaport SI (1980) Thrombosis in patients with lupus anticoagulant. Ann Int Med 1980; 92: 156–159.Google Scholar
  65. 65.
    Win N, Islam SI, Peterkin MA, Walker ID. Positive direct antiglobulin test due to antiphospholipid antibodies in normal healthy blood donors. Vox Sang 1997; 72: 182–184.PubMedCrossRefGoogle Scholar
  66. 66.
    Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996; 101: 576–583.PubMedCrossRefGoogle Scholar
  67. 67.
    Cervera R, Font J, Lopez-Soto A, Casals F, Pallares L, Bove A et al. Isotype distribution of anticardiolipin antibodies in systemic lupus eErythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis1990; 49: 109–113.Google Scholar
  68. 68.
    Delezé M, Alarcon-Segovia D, Oria CV, Sanchez-Guerrero J, Fernandez-Dominguez L, Gomez-Pacheco L et al. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1989; 16: 926–930.PubMedGoogle Scholar
  69. 69.
    Fong KY, Loizou S, Boey ML, Walport MJ. Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus. Br J Rheumatol 1992; 31: 453–455PubMedCrossRefGoogle Scholar
  70. 70.
    Molina JF, Gutierrez-Urena S, Molina J, Uribe O, Richards S, De Ceulaer C et al. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 291–96.PubMedGoogle Scholar
  71. 71.
    Cabral AR, Cabiedes J, Alarcon-Segovia D. Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that bind in vitro to stored and to bromelain-treated human erythrocytes. J Autoimmun 1990; 3: 773–787.PubMedCrossRefGoogle Scholar
  72. 72.
    Arvieux J, Scweizer B, Roussel B, Colomb MG. Autoimmune hemolytic anemia due to antiphospholipid antibodies. Vox Sang 1991; 61: 190–195.PubMedCrossRefGoogle Scholar
  73. 73.
    Sthoeger Z, Sthoeger D, Green L, Geltner. D. The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus. J Rheumatol 1993; 20: 2058–2061.PubMedGoogle Scholar
  74. 74.
    Del Papa N, Meroni PL, Barcellini W, Borghi MO, Fain C, Khamashta M et al. Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. Clin Exp Rheumatol 1992; 10: 395–399.PubMedGoogle Scholar
  75. 75.
    Arnold LW, Haughton G. Autoantibodies to phosphatidylcholine. The murine antibromelain RBC response. Ann N Y Acad Sci 1992; 651: 354–359.PubMedCrossRefGoogle Scholar
  76. 76.
    Hammond A, Rudge AC, Loizou S, Bowcock SJ, Walport MJ. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Arthritis Rheum 1989; 32: 259–264.PubMedCrossRefGoogle Scholar
  77. 77.
    Arfors L, Lefvert AK. Enrichment of antibodies against phospholipids in circulating immune complexes (CIC) in the anti-phospholipid syndrome (APLS) Clin Exp Immunol 1997; 108: 47–51.PubMedGoogle Scholar
  78. 78.
    Alarcon-Segovia D, Mestanza M, Cabiedes J, Cabral AR. The antophospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays. J Rheumatol 1997; 24: 1545–1551.PubMedGoogle Scholar
  79. 79.
    Sawamura M, Yamaguchi S, Murakami H, Amagai H, Matsushima T, Tamura J. Multiple autoantibody production in a patient with splenic lymphoma. Ann Hematol 1994; 68: 251–54.PubMedCrossRefGoogle Scholar
  80. 80.
    Guzman J, Cabral AR, Cabiedes J, Pita-Ramirez L, Alarcon-Segovia D. Antiphospholipid antibodies in patients with idiopathic autoimmune haemolytic anemia. Autoimmunity 1994; 18: 51–56.PubMedCrossRefGoogle Scholar
  81. 81.
    Lang B, Straub RH, Weber S, Rother E, Fleck M, Peter HH. Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus. Lupus 1997; 6: 652–655.PubMedCrossRefGoogle Scholar
  82. 82.
    Machin SJ. Platelet and antiphospholipid antibodies. Lupus 1996; 5: 386–387.PubMedGoogle Scholar
  83. 83.
    Porta C, Bobbio-Pallavicini E, Centurioni R, Caporali R, Montecucco C. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. J Rheumatol 1999; 20: 1625–1626.Google Scholar
  84. 84.
    Musio F, Bohen EM, Yuan CM, Welch PG. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 1998; 28: 1–19.PubMedCrossRefGoogle Scholar
  85. 85.
    Durand JM, Lefevre P, Kaplanski G, Soubeyrand J. Thrombotic microangiopathy and the antiphospholipid antibody syndrome. J Rheumatol 1991; 18: 1916–1918.PubMedGoogle Scholar
  86. 86.
    Huang JJ, Chen MW, Sung JM, Lan RR, Wang MC, Chen FF. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibody. Nephrol Dial Transplant 1998; 13: 182–186.PubMedCrossRefGoogle Scholar
  87. 87.
    McMahon LP, Smith J. The HELLP syndrome at 16 weeks gestation: possible association with antiphospholipid syndrome. Aust N Z J Obstet Gynaecol 1997; 37: 313–314.PubMedCrossRefGoogle Scholar
  88. 88.
    Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 1998; 77: 195–207.PubMedCrossRefGoogle Scholar
  89. 89.
    Montecucco C, Di Lauro M, Bobbio-Pallavicini E, Longhi M, Caporali R, DeGennaro F et al. Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura. Clin Exp Rheumatol 1987; 5: 355–358.PubMedGoogle Scholar
  90. 90.
    Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988; 23: 380–384.PubMedCrossRefGoogle Scholar
  91. 91.
    Porta C, Caporali R, Montecucco C Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadow and suspects. Haematologica 1999; 84: 260–269.PubMedGoogle Scholar
  92. 92.
    Jorfen M, Callejas JL, Formiga F, Cervera R, Font J, Ingelmo M. Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Scand J Rheumatol 1998; 27: 76–77.PubMedCrossRefGoogle Scholar
  93. 93.
    Caramaschi P, Riccetti MM, Pasini AF, Savarin T, Biasi D, Todeschini G. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature. Lupus 1988; 7: 37–41.CrossRefGoogle Scholar
  94. 94.
    Morita H, Suwa T, Daidoh H, Takeda N, Ishizuka T, Yasuda K. Case report: diabetic microangiopathic hemolytic anemia and thrombocytopenia with antiphospholipid syndrome. Am J Med Sci 1996; 311: 148–151.PubMedCrossRefGoogle Scholar
  95. 95.
    Lorini R, d’Annunzio G, Montecucco C, Caporali R, Vitali L, Pessino P et al. Anticardiolipin antibodies in children and adolescents with insulin-dependent diabetes mellitus. Eur J Pediatr 1995; 154: 105–108.PubMedCrossRefGoogle Scholar
  96. 96.
    Trent K, Neustater BR, Lottenberg R. Chronic thrombotic thrombocytopenic purpura and antiphospholipid antibodies: a report of two cases. Am J Haematol 1997; 54: 155–159.CrossRefGoogle Scholar
  97. 97.
    Ardiles LG, Olavarria F, Elgueta M, Moya P, Mezzano S. Anticardiolipin antibodies in classic pediatric hemolytic-uremic syndrome: a possible pathogenic role. Nephron 1998; 78: 278–283.PubMedCrossRefGoogle Scholar
  98. 98.
    Porta C, Buggia I, Bonomi I, Caporali R, Scatola C, Montecucco C. Nitrite and nitrate plasma levels, as markers of nitric oxide synthesis, in antiphospholipid antibodies-related conditions and in thrombotic thrombocytopenic purpura. Thromb Haemost1997; 78: 965–967.Google Scholar
  99. 99.
    Neuwelt CM, Daikh DI, Linfoot JA, Pfister DA, Young RG, Webb RL et al. Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years. Arthritis Rheum 1997; 40: 1534–1539.PubMedCrossRefGoogle Scholar
  100. 100.
    Falcini F, Taccetti G, Ermini M, Trapani S, Matucci-Cerinic M. Catstrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus. J Rheumatol 1997; 24: 389–392.PubMedGoogle Scholar
  101. 101.
    Gamba G, Montani N, Montecucco C, Caporali R, Ascari E. Purpura fulminans as clinical manifestation of atypical SLE with antiphospholipid antibodies: a case report. Haematologica 1991; 76: 426–428.PubMedGoogle Scholar
  102. 102.
    Arvieux J, Jacob MC, Roussel B, Bensa JC, Colomb MG. Neutrophil activation by anti-beta 2 glycoprotein I monoclonal antibodies via Fc gamma receptor II. J Leukocyte Biol 1995; 57: 387–394.PubMedGoogle Scholar
  103. 103.
    Paydas S, Kocak R, Zorludemir S, Baslamisli F. Bone marrow necrosis in antiphospholipid syndrome. J Clin Pathol 1997; 50: 261–262.PubMedCrossRefGoogle Scholar
  104. 104.
    Moore J, Ma DD, Concannon A. Non-malignant bone marrow necrosis: a report of two cases. Pathology 1998; 30: 318–320.PubMedCrossRefGoogle Scholar
  105. 105.
    Bulvik S, Aronson I, Ress S, Jacobs P. Extensive bone marrow necrosis associated with antiphospholipid antibodies. Am J Med 1995; 98: 572–574.PubMedCrossRefGoogle Scholar
  106. 106.
    Westerman MP, Unger L, Kucuk O, Quinn P, Lis U. Phase changes in membrane lipids in sickle red cell shed-vesicles and sickle red cells. Am J Hematol 1998; 58: 177–182.PubMedCrossRefGoogle Scholar
  107. 107.
    De Ceulaer K, Khamashta MA, Harris EN, Serjeant GR, Hughes GR. Antiphospholipid antibodies in homozygous sickle cell disease. Ann Rheum Dis 1992; 51: 671–672.PubMedCrossRefGoogle Scholar
  108. 108.
    Kucuk O, Gilman-Sachs A, Beaman K, Lis LJ, Westerman MP. Antiphospholipid antibodies in sickle cell disease. Am J Haematol 1993; 42: 380–383.CrossRefGoogle Scholar
  109. 109.
    Yeghen T, Benjamin S, Boyd O, Pumphrey C, Bevan DH. Sickle cell anemia, right atrial thrombosis, and the antiphospholipid antibody. Am J Hematol 1995; 50: 46–48.PubMedCrossRefGoogle Scholar
  110. 110.
    Montecucco C, Caporali R, De Gennaro F, Sacchi P, Gamba G, Minoli L. Autoanticorpi circolanti nell’infezione da virus dell’immunodeficienza umana (HIV). Reumatismo 1989; 41: 177–185.Google Scholar
  111. 111.
    Intrator L, Oksenhendler E, Desforges L, Bierling P. Anticardiolipin antibodies in HIV infected patients with or without thrombocytopenic purpura. Br J Haematol 1988; 68: 269.PubMedCrossRefGoogle Scholar
  112. 112.
    MacLean C, Flegg PJ, Kilpatrick DC. Anti-cardiolipin antibodies and HIV infection. Clin Exp Immunol 1990; 81: 263–266.PubMedCrossRefGoogle Scholar
  113. 113.
    Cacoub P, Musset L, Amoura Z, Guilani P, Chabre H, Lunel F et al. Anticardiolipin, anti-beta2glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc group. J Rheumatol 1997; 24: 2139–2144.PubMedGoogle Scholar
  114. 114.
    Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23: 199–204.PubMedCrossRefGoogle Scholar
  115. 115.
    Leroy V, Arvieux J, Jacob MC, Maynard-Muet M, Baud M, Zarski JP. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol 1998; 101: 468–474.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2000

Authors and Affiliations

  • C. Montecucco
  • R. Caporali

There are no affiliations available

Personalised recommendations